Balance Sheet Data
OSE Immunotherapeutics SA (OSE.PA)
4.035 €
+0.01 (+0.25%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 12.43 | 25.84 | 29.37 | 33.58 | 25.62 | 30 | 35.12 | 41.12 | 48.15 | 56.38 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | - | - | - | - | - | - | - | - | - | - |
| Account Receivables (%) | ||||||||||
| Inventories | - | - | - | - | - | - | - | - | - | - |
| Inventories (%) | ||||||||||
| Accounts Payable | 4.83 | 4.28 | 7.39 | 2.96 | 8.54 | 7.07 | 8.28 | 9.70 | 11.35 | 13.29 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.59 | -0.34 | -0.21 | -0.47 | -0.27 | -0.39 | -0.45 | -0.53 | -0.62 | -0.73 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.